AIZ
52
2
CVS
44
4
CI
42
-3
DUK
55
-2
ADSK
66
10
AAL
50
-4
CMCSA
42
-2
AN
63
2
COST
48
-8
AMGN
36
-3
AIG
56
3
CMA
70
2
BBY
41
-9
CAG
34
-3
DVA
47
-3
CCI
36
2
ES
45
5
AME
63
-2
AAP
36
-5
EFX
47
4
AIZ
52
2
CVS
44
4
CI
42
-3
DUK
55
-2
ADSK
66
10
AAL
50
-4
CMCSA
42
-2
AN
63
2
COST
48
-8
AMGN
36
-3
AIG
56
3
CMA
70
2
BBY
41
-9
CAG
34
-3
DVA
47
-3
CCI
36
2
ES
45
5
AME
63
-2
AAP
36
-5
EFX
47
4
Financhill
Back

Aldeyra Therapeutics, Inc. 10K Form

Sell
39

ALDX
Aldeyra Therapeutics, Inc.

Last Price:
$4.87
Seasonality Move:
5.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-7M
Price / Cash Flow: 0
Annual Sales: $0.82
Price / Book: 5.96

Profitability

EPS (TTM): -0.72180
Net Income (TTM): $-43.2M
Gross Margin: $-249.6K
Return on Equity: -66.61%
Return on Assets: -45.19%

Aldeyra Therapeutics, Inc. Earnings Forecast

Key Aldeyra Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 8 years.

Aldeyra Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 2.68
Quick Ratio: 2.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 8.83

ALDX Technical Analysis vs Fundamental Analysis

Sell
39
Aldeyra Therapeutics, Inc. (ALDX) is a Sell

Is Aldeyra Therapeutics, Inc. a Buy or a Sell?